Featured Research

from universities, journals, and other organizations

Commonly used defibrillators raise risk of problems, study suggests

Date:
September 1, 2011
Source:
University of Colorado Denver
Summary:
With defibrillators, simpler may be better, according to a new study. The group reviewed more than 100,000 records of cardiac patients. They found that there was more chance of surgical problems and death with devices that require electrical leads to be attached to two chambers of the heart compared to those that work on one chamber.

When it comes to defibrillators, simpler may be safer, even though more complex machines are used on a majority of patients. That's according to a new study from a team that included University of Colorado School of Medicine researcher Paul Varosy, MD. The group reviewed more than 100,000 records of cardiac patients. They found that there was more chance of surgical problems and death with devices that require electrical leads to be attached to two chambers of the heart compared to those that work on one chamber.

Although there are potential theoretical benefits, the higher-risk complex defibrillators have never been shown to result in improved survival or decreased rates of hospitalization, says Varosy, an assistant professor of medicine at the medical school.

"There is no reason for alarm, and it's important to remember that defibrillators of all kinds have clearly-established benefits in terms of reducing mortality among patients at risk for sudden cardiac death," Varosy says. "But this study does suggest that the simpler defibrillators may cause fewer short-term problems, suggesting that the routine use of dual-chamber defibrillators even in the absence of a simultaneous need for a pacemaker should be re-evaluated."

The two-chamber defibrillator is used in about six of 10 surgeries, according to Varosy, director of cardiac electrophysiology at the VA Eastern Colorado Health Care System. The study was published in the Journal of the American College of Cardiology. It examined 104,000 records of cardiac cases from 2006-07.


Story Source:

The above story is based on materials provided by University of Colorado Denver. Note: Materials may be edited for content and length.


Cite This Page:

University of Colorado Denver. "Commonly used defibrillators raise risk of problems, study suggests." ScienceDaily. ScienceDaily, 1 September 2011. <www.sciencedaily.com/releases/2011/08/110831160226.htm>.
University of Colorado Denver. (2011, September 1). Commonly used defibrillators raise risk of problems, study suggests. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2011/08/110831160226.htm
University of Colorado Denver. "Commonly used defibrillators raise risk of problems, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/08/110831160226.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins